109
Views
21
CrossRef citations to date
0
Altmetric
(RG) Obstetrics and Gynaecology

Use of an oral contraceptive containing drospirenone in an extended regimen

, , &
Pages 162-169 | Published online: 06 Jul 2009

REFERENCES

  • Muhn P, Krattenmacher R, Beier S, et al. A novel progestogen with antimineralocorticoid and antiandro- genic activity. Contraception 1995;51:99–110
  • Clarke AK, Miller SJ. The debate regarding continuous use of oral contraceptives. Ann Pharmacother 2001;35:1480–4
  • Brown C, Ling F, Wan J. A new monophasic oral contraceptive containing drospirenone effect on pre- menstrual symptoms. J Reprod Med 2002;47:14–22
  • Apter D, Borsos A, Baumgärtner W, et al. Effect of an oral contraceptive containing drospirenone and ethinylestradiol on general well-being and fluid-related symptoms. Eur J Contracept Reprod Health Care 2003;8:37–51
  • Fuhrmann U, Krattenmacher R, Slater EP, et al. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential. Contraception 1996;54:243–51
  • Singh BB, Berman BM, Simpson RL, et al. Incidence of premenstrual syndrome and remedy usage: a national probability sample study. Altern Ther Health Med 1998; 3:75–9
  • Joffe H, Cohen LS. Estrogen, serotonin and mood disturbance: where is the therapeutic bridge? Biol Psychiatry 1998;44:798–811
  • Krattenmacher R. Drospirenone: pharmacology and pharmacokinetics of a unique progestogen. Contraception 2000;62:29–38
  • Glasier AF, Smith KB, van der Spuy ZM, et al. Amenorrhea associated with contraception – an international study on acceptability. Contraception 2003; 67:1–8
  • Brosens IA, Pijenenborg R. Comparative study of the oestrogenic effect of ethinylestradiol and mestranol on the endometrium. Contraception 1976;14:679–85
  • Lüdicke F, Johannisson E, Helmerhorst FM, et al. Effect of a combined oral contraceptive containing 3 mg of drospirenone and 30 mg of ethinylestradiol on the human endometrium. Fertil Steril 2001;76:102–7
  • Foidart J-M, Wuttke W, Bouw GM, et al. A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel. Eur J Contracept Reprod Health Care 2000; 5:124–34
  • Mueck AG, Römer T. Stoffwechsel und Hormon- substitution. Stuttgart: Thieme, 2002:56–64;95–102; 167–71
  • Reiners K. Zur Problematik der zyklusabhängigen Migräne. Gynäkologe 1989;22:326–31

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.